Past and Present VIP Attendees
SVP Global Engineering
Medimmune
GM Manufacturing
Eisai Inc.
Head Global Pharma Engineering & Innovation Quality Productivity
Novartis
Exec Director USP, Biotech Process
Schering-Plough Corporation
SVP Global Engineering
Medimmune
GM Manufacturing
Eisai Inc.
Head Global Pharma Engineering & Innovation Quality Productivity
Novartis
Exec Director USP, Biotech Process
Schering-Plough Corporation
Previous Summits
Pharma Manufacturing Summit 2011
7th - 9th June 2011
The Fairmont Le Montreux Palace, Switzerland
The Next Generation Pharmaceutical Summit 2011 will once again serve as an arena for senior level executives to engage in clear and focused dialogue with their peers and examine their management objectives in a relaxed and vibrant environment.
Next Generation Pharma Manufacturing Summit 2010
12th - 14th October 2010
Hotels Van Oranje, The Netherlands
The Next Generation Pharmaceutical Summit October 2010 will once again serve as an arena for senior level executives to engage in clear and focused dialogue with their peers and examine their management objectives in a relaxed and vibrant environment.
NGP Europe Summit March 2010
29th - 31st March 2010
Hotel CampoReal Golf Resort & Spa, Portugal
The Next Generation Pharmaceutical Summit March 2010 once again served as an arena for senior level executives to engage in clear and focused dialogue with their peers and examine their management objectives in a relaxed and vibrant environment.
NGP Europe Summit Sept 2009
15th - 17th September 2009
The Park Hotel, Bremen, Germany
The Pharmaceutical and Biopharmaceutical industry has the challenge of finding more innovative ways to get products to market more effectively and profitably. In this new era of global commercialisation the industry needs to overhaul their business models to improve the agility and flexibility of their organisations "go to market" strategy.
NGP Europe Summit Feb 2009
24th - 26th February 2009
Fairmont Le Montreux Palace, Lake Geneva, Switzerland
The Pharmaceutical and Biopharmaceutical industry has the challenge of finding more innovative ways to get products to market more effectively and profitably. In this new era of global commercialisation the industry needs to overhaul their business models to improve the agility and flexibility of their organisations “go to market” strategy.
Source: www.ngpsummit.eu.com© 2012 GDS International Ltd. All rights reserved.
